Increased Parental Anxiety With Increased Diabetes Risk

Share this content:
Increased Parental Anxiety With Increased Diabetes Risk
Increased Parental Anxiety With Increased Diabetes Risk

WEDNESDAY, July 12, 2017 (HealthDay News) -- Parents of children at increased genetic risk for type 1 diabetes and with positive islet autoantibody (IA) testing have increased anxiety, according to a study published online June 29 in Diabetes Care.

Suzanne Bennett Johnson, Ph.D., from the Florida State University College of Medicine in Tallahassee, and colleagues examined parent anxiety in response to genetic and IA testing in 6,799 children at increased genetic risk for type 1 diabetes in The Environmental Determinants of Diabetes in the Young study. Parental anxiety was assessed with the State Anxiety Inventory, which was completed when the child was 3, 6, and 15 months old, and annually thereafter. IA testing was conducted every three months for four years and every six months thereafter.

The researchers found that parents had high levels of anxiety in response to their child's increased genetic type 1 diabetes risk at study inception, with mothers more anxious than fathers, and parents with diabetes in the family more anxious than those without diabetes in the family. Parent anxiety decreased to normal levels in response to repeated IA-negative test results. In parents faced with an IA-positive (IA+) test result, anxiety increased; particularly high levels of anxiety were seen for parents faced with two or more types of IA+ results (all P < 0.001).

"IA+ results heighten parent anxiety, and parents faced with two or more types of IA+ results may experience considerable anxiety for longer periods," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »